Evidence map›Paper›PMID 39021625›Full record

ArticleFrontiers in microbiology2024

Viability-PCR for the selective detection of

Stefania Catone, Serena Iannantuono, Domenico Genovese, Christina Von Hunolstein, Giovanna Franciosa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stefania Catone *Biologicals and Biotechnologicals Unit, Istituto Superiore di Sanità, National Center for the Evaluation and Control of Medicines, Rome, Italy.
Serena Iannantuono *Biologicals and Biotechnologicals Unit, Istituto Superiore di Sanità, National Center for the Evaluation and Control of Medicines, Rome, Italy.
Domenico GenoveseBiologicals and Biotechnologicals Unit, Istituto Superiore di Sanità, National Center for the Evaluation and Control of Medicines, Rome, Italy.
Christina Von HunolsteinBiologicals and Biotechnologicals Unit, Istituto Superiore di Sanità, National Center for the Evaluation and Control of Medicines, Rome, Italy.
Giovanna FranciosaBiologicals and Biotechnologicals Unit, Istituto Superiore di Sanità, National Center for the Evaluation and Control of Medicines, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To exert their beneficial effects, microorganisms used in live bacteria-containing products must be viable and present in certain amounts. In this study, we developed a viability assay based on quantitative PCR coupled with propidium monoazide for the identification and enumeration of viable

Indexed as

Bifidobacterium bifidumLactobacillus acidophiluslive bacteria-containing productsplate count enumerationqPCRviability-PCR

Identifiers

PMID39021625
PMCPMC11251893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.